Medication info
Coroza Tablet 50 mg (Losartan Potassium)

Coroza Tablet 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200600688 · Notified 2006.02.28 · Insurance code 698500370

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after the start of treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary for elderly patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment - Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment - Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced intravascular effective blood volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). Patients with hepatic impairment: Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • nephropathy
View approved original text

This medication helps lower blood pressure in hypertensive patients, thereby reducing the risk of cardiovascular diseases. It is also used to protect kidney function in patients with hypertension among those with type 2 diabetes, thus slowing the progression of nephropathy. It is effectively utilized for the prevention and improvement of complications associated with hypertension.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after the start of treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary for elderly patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment - Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment - Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced intravascular effective blood volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). Patients with hepatic impairment: Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should not be used by pregnant women or those who may become pregnant. Patients with allergic reactions to this medication, severely impaired liver function, history of angioedema, or specific genetic disorders should not use this medication. Elderly patients, those with kidney dysfunction, and patients with hyperkalemia should use this medication with caution, as there is a risk of rapid drops in blood pressure, and their conditions should be closely monitored. Although this medication is generally safe to use, side effects such as muscle cramps, dizziness, and upper respiratory infections may occur, and in severe cases, serious adverse reactions like angioedema or renal failure may arise. During the administration of this medication, liver and kidney functions, as well as serum electrolyte levels, should be regularly monitored to ensure no abnormalities, especially regarding the potential occurrence of hyperkalemia. When taken in conjunction with other antihypertensive agents or potassium-sparing diuretics and potassium supplements, interactions may lead to hyperkalemia or worsening kidney function, so it is essential to consult a doctor. This medication is not recommended for nursing women, and if it must be taken, discontinuation of breastfeeding is advised. In cases of overdose, hypotension or cardiac arrhythmias may occur; therefore, adherence to dosage is essential, and immediate consultation with healthcare professionals is necessary should any abnormal symptoms arise. Dizziness may occur while driving or operating machinery during the use of this medication, so caution is advised, especially at the beginning of treatment or when dosage is adjusted.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 130 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • abdominal distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm scaling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • reduced libido
  • memory disorder
  • migraine
  • nerve hyperexcitability
  • sensory disturbances
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • drowsiness
  • tremors
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitive reactions
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation in the eyes
  • pain
  • conjunctivitis
  • taste disturbances
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urinary tract infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythroderma
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystole
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. Additionally, avoid excessively hot or cold places, and store it at a temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.